Literature DB >> 35005919

Review of Recent Advances and Their Improvement in the Effectiveness of Hydrogel-Based Targeted Drug Delivery: A Hope for Treating Cancer.

Muskan Sonker1, Sushant Bajpai2, Mohd Ashhar Khan3, Xiaojun Yu4, Saurabh Kr Tiwary3, Nehil Shreyash3.   

Abstract

Using hydrogels for delivering cancer therapeutics is advantageous in pharmaceutical usage as they have an edge over traditional delivery, which is tainted due to the risk of toxicity that it imbues. Hydrogel usage leads to the development of a more controlled drug release system owing to its amenability for structural metamorphosis, its higher porosity to seat the drug molecules, and its ability to shield the drug from denaturation. The thing that makes its utility even more enhanced is that they make themselves more recognizable to the body tissues and hence can stay inside the body for a longer time, enhancing the efficiency of the delivery, which otherwise is negatively affected since the drug is identified by the human immunity as a foreign substance, and thus, an attack of the immunity begins on the drug injected. A variety of hydrogels such as thermosensitive, pH-sensitive, and magnetism-responsive hydrogels have been included and their potential usage in drug delivery has been discussed in this review that aims to present recent studies on hydrogels that respond to alterations under a variety of circumstances in "reducing" situations that mimic the microenvironment of cancerous cells.

Entities:  

Keywords:  Bio-inspired hydrogels; Cancer therapeutics; Doxorubicin; Drug delivery; Hydrogel nanocomposites

Mesh:

Substances:

Year:  2021        PMID: 35005919     DOI: 10.1021/acsabm.1c00857

Source DB:  PubMed          Journal:  ACS Appl Bio Mater        ISSN: 2576-6422


  2 in total

1.  Intraperitoneal administration of thermosensitive hydrogel Co-loaded with norcantharidin nanoparticles and oxaliplatin inhibits malignant ascites of hepatocellular carcinoma.

Authors:  Susu Xiao; Yu Wang; Wenqiong Ma; Ping Zhou; Biqiong Wang; Zhouxue Wu; Qian Wen; Kang Xiong; Yanlin Liu; Shaozhi Fu
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

Review 2.  Advances in the therapeutic application and pharmacological properties of kinsenoside against inflammation and oxidative stress-induced disorders.

Authors:  Li Lu; Yuan Xiong; Ze Lin; Xiangyu Chu; Adriana C Panayi; Yiqiang Hu; Juan Zhou; Bobin Mi; Guohui Liu
Journal:  Front Pharmacol       Date:  2022-10-04       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.